Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research
- PMID: 32801208
- PMCID: PMC7430485
- DOI: 10.1136/bmjopen-2020-039652
Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research
Abstract
Objectives: The aim of this study was to conduct a rapid systematic review and meta-analysis of estimates of the incubation period of COVID-19.
Design: Rapid systematic review and meta-analysis of observational research.
Setting: International studies on incubation period of COVID-19.
Participants: Searches were carried out in PubMed, Google Scholar, Embase, Cochrane Library as well as the preprint servers MedRxiv and BioRxiv. Studies were selected for meta-analysis if they reported either the parameters and CIs of the distributions fit to the data, or sufficient information to facilitate calculation of those values. After initial eligibility screening, 24 studies were selected for initial review, nine of these were shortlisted for meta-analysis. Final estimates are from meta-analysis of eight studies.
Primary outcome measures: Parameters of a lognormal distribution of incubation periods.
Results: The incubation period distribution may be modelled with a lognormal distribution with pooled mu and sigma parameters (95% CIs) of 1.63 (95% CI 1.51 to 1.75) and 0.50 (95% CI 0.46 to 0.55), respectively. The corresponding mean (95% CIs) was 5.8 (95% CI 5.0 to 6.7) days. It should be noted that uncertainty increases towards the tail of the distribution: the pooled parameter estimates (95% CIs) resulted in a median incubation period of 5.1 (95% CI 4.5 to 5.8) days, whereas the 95th percentile was 11.7 (95% CI 9.7 to 14.2) days.
Conclusions: The choice of which parameter values are adopted will depend on how the information is used, the associated risks and the perceived consequences of decisions to be taken. These recommendations will need to be revisited once further relevant information becomes available. Accordingly, we present an R Shiny app that facilitates updating these estimates as new data become available.
Keywords: epidemiology; public health.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
Figures






Similar articles
-
Impact of non-pharmaceutical interventions for reducing transmission of COVID-19: a systematic review and meta-analysis protocol.BMJ Open. 2020 Oct 22;10(10):e041383. doi: 10.1136/bmjopen-2020-041383. BMJ Open. 2020. PMID: 33093038 Free PMC article.
-
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.BMJ Open. 2020 Aug 5;10(8):e039856. doi: 10.1136/bmjopen-2020-039856. BMJ Open. 2020. PMID: 32759252 Free PMC article.
-
COVID-19 in pregnant women: A systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:543-558. doi: 10.1016/j.ejogrb.2020.07.006. Epub 2020 Jul 16. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32713730 Free PMC article.
-
Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Jun 1;3(6):e2011335. doi: 10.1001/jamanetworkopen.2020.11335. JAMA Netw Open. 2020. PMID: 32525549 Free PMC article.
-
Evidence for transmission of COVID-19 prior to symptom onset.Elife. 2020 Jun 22;9:e57149. doi: 10.7554/eLife.57149. Elife. 2020. PMID: 32568070 Free PMC article.
Cited by
-
A Scenario-Based Evaluation of COVID-19-Related Essential Clinical Resource Demands in China.Engineering (Beijing). 2021 Jul;7(7):948-957. doi: 10.1016/j.eng.2021.03.020. Epub 2021 May 21. Engineering (Beijing). 2021. PMID: 34035977 Free PMC article.
-
In pursuit of the right tail for the COVID-19 incubation period.Public Health. 2021 May;194:149-155. doi: 10.1016/j.puhe.2021.03.011. Epub 2021 Mar 26. Public Health. 2021. PMID: 33915459 Free PMC article. Review.
-
Interpreting vaccine efficacy trial results for infection and transmission.medRxiv [Preprint]. 2021 May 27:2021.02.25.21252415. doi: 10.1101/2021.02.25.21252415. medRxiv. 2021. Update in: Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. PMID: 33655276 Free PMC article. Updated. Preprint.
-
Is minor surgery safe during the COVID-19 pandemic? A multi-disciplinary study.PLoS One. 2021 May 11;16(5):e0251122. doi: 10.1371/journal.pone.0251122. eCollection 2021. PLoS One. 2021. PMID: 33974628 Free PMC article.
-
Construction of the Infection Curve of Local Cases of COVID-19 in Hong Kong using Back-Projection.Int J Environ Res Public Health. 2020 Sep 21;17(18):6909. doi: 10.3390/ijerph17186909. Int J Environ Res Public Health. 2020. PMID: 32967321 Free PMC article.
References
-
- Brookmeyer R. Incubation period of infectious diseases. Wiley StatsRef: Statistics Reference Online, 2014: 1–8.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials